Applied Therapeutics Inc 's ROA from the third quarter of 2025 to the third quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Applied Therapeutics Inc 's ROA in the third quarter of 2025?
Applied Therapeutics Inc recorded a cumulative net loss of $-18 million during 12 months ending in the third quarter of 2025, resulting in a negative return on assets (ROA) of -33.7%.

However, within the Healthcare sector 472 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2025 quarter, so far to 3823, from total ROA ranking in the second quarter of 2025 at 4426.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter
Y / Y Total Assets Change	-67.74 %	-70.78 %	-62.37 %	58.02 %	135.79 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-18	-68	-44	-106	-187
Return On Assets (TTM)	-33.7 %	-94.26 %	-46.06 %	-89.47 %	-170.12 %
APLT's Total Ranking	# 3823	# 4426	# 4093	# 5157	# 4816
Total Assets (TTM) in million	34	37	57	87	107
Seq. Total Assets Change	-7.95 %	-34.38 %	-34.32 %	-18.69 %	-16.6 %
Seq. Net Income Change	-	-	-	-	-

APLT's 5 Years Annual ROA >> Back to APLT Management Effectiveness >> Compare APLT ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 193
Sector	# 473
Overall	# 3778

Return On Assets Statistics
High	Average	Low
-27.9 %	-114.25 %	-275.83 %
(Mar 31 2020)		(Dec 31 2023)

Financial Statements
Applied Therapeutics Inc 's Assets	$ 34 million	APLT's Balance sheet
Applied Therapeutics Inc 's Income	$ -19 million	Quarterly APLT's Income Statement
APLT's Income by Division		See APLT's Income by Division

Annual Return On Assets	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021	(Dec 31 2020) FY 2020
Y / Y Total Assets Change	58.02 %	43.14 %	-57.15 %	-14.46 %	117.02 %
Total Assets in million	87	55	38	89	105
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-106	-120	-83	-106	-94
Annual Return On Assets	-121.9 %	-218.41 %	-215.38 %	-118.11 %	-89.91 %

APLT's 5 Years Annual ROA >> Back to APLT Management Effectiveness >> Compare APLT ROA to its Competitors

More Return On Assets Ratios
APLT's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
APLT's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for APLT's Competitors
Subscribers only: Roa for Applied Therapeutics Inc 's Suppliers
Subscribers only: Return On Assets for APLT's Customers

You may also want to know
APLT's Roi	APLT's Inventory Turnover Ratio	APLT's Growth Rates	APLT's Dividend Comparisons
	APLT's Profitability Ratios	APLT's Asset Turnover Ratio	APLT's Dividend Growth
APLT's Roe	APLT's Valuation Ratios	APLT's Financial Strength Ratios	APLT's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2025, within Healthcare Sector

ROA

Date modified: 2026-09-18T13:11:06+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.